dc.creator | Montero Pérez, Olalla | es |
dc.creator | Salazar González, Fernando | es |
dc.creator | Sánchez Gómez, Ernesto | es |
dc.creator | Pérez Guerrero, María Concepción | es |
dc.date.accessioned | 2024-04-26T10:39:12Z | |
dc.date.available | 2024-04-26T10:39:12Z | |
dc.date.issued | 2024-04-21 | |
dc.identifier.citation | Montero Pérez, O., Salazar González, F., Sánchez Gómez, E. y Pérez Guerrero, M.C. (2024). Impact of pharmaceutical care for asthma patients on health‐related outcomes: An umbrella review. Pharmacology Research & Perspectives, 12 (3), e1195. https://doi.org/10.1002/prp2.1195. | |
dc.identifier.issn | 2052-1707 | es |
dc.identifier.uri | https://hdl.handle.net/11441/157198 | |
dc.description.abstract | Recent systematic reviews suggest that pharmacists' interventions in asthma patients have a positive impact on health-related outcomes. Nevertheless, the association is not well established, and the role of clinical pharmacists is poorly
represented. The aim of this overview of systematic reviews is to identify published
systematic reviews assessing the impact of pharmacists' interventions on healthrelated outcomes measured in asthma patients. PubMed, Embase, Scopus, and
Cochrane Library were searched from inception to December 2022. Systematic
reviews of all study designs and settings were included. Methodological quality
was assessed using AMSTAR 2. Two investigators performed study selection, quality assessment and data collection independently. Nine systematic reviews met the
inclusion criteria. Methodological quality was rated as high in one, low in two, and
critically low in six. Reviews included 51 primary studies reporting mainly quality
of life, asthma control, lung capacity, and therapeutic adherence. Only four studies
were carried out in a hospital setting and only two reviews stated the inclusion of
severe asthma patients. The quality of the systematic reviews was generally low,
and this was the major limitation of this overview of systematic reviews. However,
solid evidence supports that pharmaceutical care improves health-related outcomes in asthma patients. | es |
dc.format | application/pdf | es |
dc.format.extent | 12 p. | es |
dc.language.iso | eng | es |
dc.publisher | Wiley Open Access | es |
dc.relation.ispartof | Pharmacology Research & Perspectives, 12 (3), e1195. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | asthma | es |
dc.subject | clinical pharmacist | es |
dc.subject | outcome assessment | es |
dc.subject | health care | es |
dc.subject | pharmaceutical care | es |
dc.subject | systematic review | es |
dc.title | Impact of pharmaceutical care for asthma patients on health‐related outcomes: An umbrella review | es |
dc.type | info:eu-repo/semantics/article | es |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Farmacología | es |
dc.relation.publisherversion | https://doi.org/10.1002/prp2.1195 | es |
dc.identifier.doi | 10.1002/prp2.1195 | es |
dc.journaltitle | Pharmacology Research & Perspectives | es |
dc.publication.volumen | 12 | es |
dc.publication.issue | 3 | es |
dc.publication.initialPage | e1195 | es |